Terms: = Pancreatic cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Diagnosis
115 results:
1. A Single-Molecule Bioelectronic Portable Array for Early diagnosis of pancreatic cancer Precursors.
Genco E; Modena F; Sarcina L; Björkström K; Brunetti C; Caironi M; Caputo M; Demartis VM; Di Franco C; Frusconi G; Haeberle L; Larizza P; Mancini MT; Österbacka R; Reeves W; Scamarcio G; Scandurra C; Wheeler M; Cantatore E; Esposito I; Macchia E; Torricelli F; Viola FA; Torsi L
Adv Mater; 2023 Oct; 35(42):e2304102. PubMed ID: 37452695
[TBL] [Abstract] [Full Text] [Related]
2. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinoma.
Varol U; Cakır E; Aktas S; Altun ZS; Dilek FH; Butun O; Salman T; Unlu AGD; Alacacioglu A; Somali I
Pol J Pathol; 2023; 74(1):18-28. PubMed ID: 37306349
[TBL] [Abstract] [Full Text] [Related]
4. [Immunotherapy in Hepatogastroenterology - update 2022: efficacy and immune-related adverse events].
Krimmel L; Quante M; Bengsch B
Dtsch Med Wochenschr; 2023 Mar; 148(6):294-300. PubMed ID: 36878227
[TBL] [Abstract] [Full Text] [Related]
5. Molecular imaging Theranostics of Neuroendocrine Tumors.
Fortunati E; Bonazzi N; Zanoni L; Fanti S; Ambrosini V
Semin Nucl Med; 2023 Jul; 53(4):539-554. PubMed ID: 36623974
[TBL] [Abstract] [Full Text] [Related]
6. Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic cancer.
Yokoyama S; Iwaya H; Akahane T; Hamada T; Higashi M; Hashimoto S; Tanoue S; Ohtsuka T; Ido A; Tanimoto A
Diagn Cytopathol; 2022 Nov; 50(11):499-507. PubMed ID: 36181430
[TBL] [Abstract] [Full Text] [Related]
7. Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
Xu W; Zhang M; Liu L; Yin M; Xu C; Weng Z
PLoS One; 2022; 17(6):e0269612. PubMed ID: 35709153
[TBL] [Abstract] [Full Text] [Related]
8. A large-area organic transistor with 3D-printed sensing gate for noninvasive single-molecule detection of pancreatic mucinous cyst markers.
Sarcina L; Viola F; Modena F; Picca RA; Bollella P; Di Franco C; Cioffi N; Caironi M; Österbacka R; Esposito I; Scamarcio G; Torsi L; Torricelli F; Macchia E
Anal Bioanal Chem; 2022 Jul; 414(18):5657-5669. PubMed ID: 35410389
[TBL] [Abstract] [Full Text] [Related]
9. Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance of Fe
Dong Q; Jia X; Wang Y; Wang H; Liu Q; Li D; Wang J; Wang E
J Nanobiotechnology; 2022 Feb; 20(1):94. PubMed ID: 35197099
[TBL] [Abstract] [Full Text] [Related]
10. A case of ectopic pancreas of the stomach accompanied by intraductal papillary mucinous neoplasm with GNAS mutation.
Nambu N; Yamasaki T; Nakagomi N; Kumamoto T; Nakamura T; Tamura A; Tomita T; Miwa H; Shinohara H; Hirota S
World J Surg Oncol; 2021 Oct; 19(1):309. PubMed ID: 34674710
[TBL] [Abstract] [Full Text] [Related]
11. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of pancreatic cancer.
Markov SD; Caffrey TC; O'Connell KA; Grunkemeyer JA; Shin S; Hanson R; Patil PP; Shukla SK; Gonzalez D; Crawford AJ; Vance KE; Huang Y; Eberle KC; Radhakrishnan P; Grandgenett PM; Singh PK; Madiyalakan R; Daniels-Wells TR; Penichet ML; Nicodemus CF; Poole JA; Jaffee EM; Hollingsworth MA; Mehla K
Mol Cancer Ther; 2021 Dec; 20(12):2457-2468. PubMed ID: 34625505
[TBL] [Abstract] [Full Text] [Related]
12. Primary ALK-Positive Large B Cell Lymphoma of Pancreas.
Kushwaha P; Singh M; Vindal A; Verma N; Jain S
J Gastrointest Cancer; 2022 Sep; 53(3):830-833. PubMed ID: 34374890
[TBL] [Abstract] [Full Text] [Related]
13. A case of intraductal tubulopapillary neoplasm of the pancreas in a branch duct: a rare case report and literature review.
Yamaguchi A; Hamada T; Wada K; Moriuchi R; Tao K; Konishi H; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Ishiyama K; Hadano N; Sudo T; Toyota N; Zaitsu J; Kuraoka K; Kohno H
BMC Gastroenterol; 2021 Apr; 21(1):162. PubMed ID: 33849435
[TBL] [Abstract] [Full Text] [Related]
14. Expression of Calretinin, Marker of Mesothelial Differentiation, in pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall.
Askan G; Basturk O
Turk Patoloji Derg; 2021; 37(2):115-120. PubMed ID: 33432559
[TBL] [Abstract] [Full Text] [Related]
15. pancreatic acinar cell carcinoma with a ductal adenocarcinoma component: a case report and analysis of the histogenesis of the tumor.
Kimura T; Tabata S; Togawa T; Onchi H; Iida A; Sato Y; Goi T
World J Surg Oncol; 2020 Sep; 18(1):238. PubMed ID: 32891173
[TBL] [Abstract] [Full Text] [Related]
16. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy.
Wang S; You L; Dai M; Zhao Y
J Cell Mol Med; 2020 Sep; 24(18):10279-10289. PubMed ID: 32745356
[TBL] [Abstract] [Full Text] [Related]
17. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract] [Full Text] [Related]
18. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract] [Full Text] [Related]
19. pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.
Kim H; An S; Lee K; Ahn S; Park DY; Kim JH; Kang DW; Kim MJ; Chang MS; Jung ES; Kim JM; Choi YJ; Jin SY; Chang HK; Cho MY; Kang YK; Kang M; Ahn S; Kim YW; Hong SM;
Cancer Res Treat; 2020 Jan; 52(1):263-276. PubMed ID: 31319641
[TBL] [Abstract] [Full Text] [Related]
20. Addition of analysis of KRAS mutation or immunohistochemistry with muc1 and carcinoembryonic antigen improves the diagnostic performance of fine needle aspiration cytology for the diagnosis of pancreatic carcinoma.
Gómez-Peñaloza C; Serrano-Arévalo ML; Villegas-González LF; Flores-Hernández L; Lino-Silva LS; Ruiz-García EB; Diaz-Chávez J
Cytopathology; 2019 Sep; 30(5):485-491. PubMed ID: 30929285
[TBL] [Abstract] [Full Text] [Related]
[Next]
